1968B |
Eszopiclone / Zopiclone, Blood |
1968SP |
Eszopiclone / Zopiclone, Serum/Plasma |
1968TI |
Eszopiclone / Zopiclone, Tissue |
1968U |
Eszopiclone / Zopiclone, Urine |
2479B |
Ketamine and Metabolite, Blood |
2479FL |
Ketamine and Metabolite, Fluid |
2479SP |
Ketamine and Metabolite, Serum/Plasma |
2479TI |
Ketamine and Metabolite, Tissue |
2479U |
Ketamine and Metabolite, Urine |
4086B |
Ramelteon and Metabolite, Blood |
4086SP |
Ramelteon and Metabolite, Serum/Plasma |
4086U |
Ramelteon and Metabolite, Urine |
4236B |
Suvorexant, Blood |
4236SP |
Suvorexant, Serum/Plasma |
4815B |
Xylazine, Blood |
4815SP |
Xylazine, Serum/Plasma |
4815TI |
Xylazine, Tissue |
4815U |
Xylazine, Urine |
6303B |
Firefighter Core Baseline Profile, Blood |
8103B |
Environmental Exposure Screen, Blood |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9188B |
Ketamine and Metabolite Screen, Blood |
9188SP |
Ketamine and Metabolite Screen, Serum/Plasma |
9188U |
Ketamine and Metabolite Screen, Urine |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |